Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Apiam Animal Health partners with Veyx-Pharma to distribute innovative products in Australia

  • In News
  • June 7, 2024
  • Mitchell Korver
Apiam Animal Health partners with Veyx-Pharma to distribute innovative products in Australia

Apiam Animal Health (ASX: AHX) has announced a strategic partnership with the German company Veyx-Pharma to distribute their cutting-edge products across Australia. This agreement marks a significant milestone for both companies as they expand their reach and bring new technology to the Australian market.

Over the past six months, Apiam has been rigorously researching Veyx-Pharma’s lead product, with a particular focus on its applications for Australian pig farmers. The culmination of this research will be the product’s launch in the Australian pig industry, slated to occur within the next few months. This innovative product is anticipated to bring substantial benefits to local farmers, enhancing productivity.

Apiam’s CEO, Dr Chris Richards, expressed his enthusiasm for the partnership. “We are extremely excited to bring Veyx-Pharma’s advanced technology to Australia. This collaboration allows us to provide our farmers with state-of-the-art solutions that can significantly improve their operations,” said Dr Richards. 

Veyx-Pharma, known for its innovative approach and high-quality products in animal health, sees this partnership as a significant step towards global expansion. Dr Silke Engl, CEO of Veyx-Pharma was equally enthused.

“This is an exciting opportunity for Veyx-Pharma. Expanding into the Australian market allows us to support veterinarians and farmers with our advanced solutions, fostering better animal health and productivity outcomes in a new region,” said Dr Engl. 

The introduction of Veyx-Pharma’s products in Australia is expected to set a new benchmark in the industry, particularly within the pig farming sector. Apiam’s established network and expertise in the local market, combined with Veyx-Pharma’s innovative products, promise a fruitful collaboration that will benefit the Australian agriculture industry.

As the launch date approaches, both companies are committed to ensuring a smooth rollout and providing comprehensive support to Australian farmers, guaranteeing the successful integration of these new products into their farming practices. This partnership not only signifies growth and innovation but also reinforces the shared commitment of Apiam and Veyx-Pharma to advancing animal health and farm productivity globally.

  • About
  • Latest Posts
Mitchell Korver
Mitch Korver is a Business Writer focused on high-growth companies listed on the ASX in the small and medium cap space.
Latest posts by Mitchell Korver (see all)
  • Refurbished tech gives Harris Technology a second life - August 31, 2026
  • Harris Technology’s refurbished boom signals FY26 profit inflection - April 21, 2026
  • Capral sees lift in sales and outlook as with Government push for new home builds - February 26, 2026
  •  
  •  
  •  
  •  
  • AHX
  • apiam
  • Apiam Animal Health
  • ASX: AHX
  • Chris Richards
  • silke engl
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    April 2, 2025, 10:40 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/companion-animal-health

    Reply
  • About
  • Latest Posts
Mitchell Korver
Mitch Korver is a Business Writer focused on high-growth companies listed on the ASX in the small and medium cap space.
Latest posts by Mitchell Korver (see all)
  • Refurbished tech gives Harris Technology a second life - August 31, 2026
  • Harris Technology’s refurbished boom signals FY26 profit inflection - April 21, 2026
  • Capral sees lift in sales and outlook as with Government push for new home builds - February 26, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Mitchell Korver
Mitch Korver is a Business Writer focused on high-growth companies listed on the ASX in the small and medium cap space.
Latest posts by Mitchell Korver (see all)
  • Refurbished tech gives Harris Technology a second life - August 31, 2026
  • Harris Technology’s refurbished boom signals FY26 profit inflection - April 21, 2026
  • Capral sees lift in sales and outlook as with Government push for new home builds - February 26, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.